These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21851186)

  • 21. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
    Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
    Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure and body mass index in long-term survivors of testicular cancer.
    Sagstuen H; Aass N; Fosså SD; Dahl O; Klepp O; Wist EA; Wilsgaard T; Bremnes RM
    J Clin Oncol; 2005 Aug; 23(22):4980-90. PubMed ID: 16051950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of quality of life, anxiety and depression in testicular cancer patients during chemotherapy and after anticancer treatment].
    Osmańska M; Borkowska A; Makarewicz R
    Psychiatr Pol; 2010; 44(4):543-56. PubMed ID: 20919505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
    Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment on: paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
    Salonia A
    Eur Urol; 2010 Jul; 58(1):140-1. PubMed ID: 20395038
    [No Abstract]   [Full Text] [Related]  

  • 26. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
    Oldenburg J; Kraggerud SM; Cvancarova M; Lothe RA; Fossa SD
    J Clin Oncol; 2007 Feb; 25(6):708-14. PubMed ID: 17228018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
    Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
    J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of childhood cancer survivors in Sweden: a population-based study of education, employment, and income.
    Boman KK; Lindblad F; Hjern A
    Cancer; 2010 Mar; 116(5):1385-91. PubMed ID: 20087961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.
    Mykletun A; Dahl AA; Haaland CF; Bremnes R; Dahl O; Klepp O; Wist E; Fosså SD
    J Clin Oncol; 2005 May; 23(13):3061-8. PubMed ID: 15860864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.
    Nord C; Olofsson SE; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Ståhl E; Neovius M; Jerkeman M; Smedby KE
    Acta Oncol; 2015 Nov; 54(10):1770-80. PubMed ID: 25833328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Burgerhof JG; Hoekstra HJ; Sluiter WJ; Gietema JA
    Eur J Cancer; 2004 Mar; 40(5):701-6. PubMed ID: 15010071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Issues around testicular carcinoma].
    Nuver J; Oosting SF; Gietema JA
    Ned Tijdschr Geneeskd; 2011; 155(45):A4092. PubMed ID: 22085577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
    Schagen SB; Boogerd W; Muller MJ; Huinink WT; Moonen L; Meinhardt W; Van Dam FS
    Acta Oncol; 2008; 47(1):63-70. PubMed ID: 17934892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of testicular and second cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2021-8. PubMed ID: 10584566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.